Alexander Roediger
Impact in
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
-
- Global Cancer Incidence and Screening
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 13
- Economic and Financial Impacts of Cancer 10
- Pharmaceutical Economics and Policy 9
- Innovation Policy and R&D 2
-
- Health Literacy and Information Accessibility 2
- Co-authors
- Lydia Makaroff (2 shared papers)Nils Wilking (2 shared papers)Kristine Sørensen (2 shared papers)Gisela Kobelt (2 shared papers)Christoph Zielinski (2 shared papers)Thomas D. Szucs (3 shared papers)Andrea Laslop (1 shared paper)Anna Bucsics (1 shared paper)
- Journals
- Generics and Biosimilars Initiative Journal (2 papers)Health Policy (2 papers)Frontiers in Public Health (2 papers)Journal of Cancer Policy (2 papers)European Journal of Public Health (2 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Alexander Roediger
21 papers receiving 210 citations
Peers
Comparison fields: 5 of 51
- Economics and Econometrics 63
- Oncology 39
- Immunology 28
- Virology 6
- Pulmonary and Respiratory Medicine 33
Countries citing papers authored by Alexander Roediger
This map shows the geographic impact of Alexander Roediger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Roediger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Roediger more than expected).
Fields of papers citing papers by Alexander Roediger
This network shows the impact of papers produced by Alexander Roediger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Roediger. The network helps show where Alexander Roediger may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Roediger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 36 | |
| 2 | 2019 | 32 | |
| 3 | 2020 | 24 | |
| 4 | 2017 | 20 | |
| 5 | 2023 | 19 | |
| 6 | 2022 | 16 | |
| 7 | 2009 | 14 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 8 | |
| 10 | 2019 | 7 | |
| 11 | 2014 | 7 | |
| 12 | 2019 | 6 | |
| 13 | 2023 | 2 | |
| 14 | 2019 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2018 | 1 |
About Alexander Roediger
Alexander Roediger is a scholar working on Economics and Econometrics, General Health Professions, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 23 papers that have together received 213 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (10 papers), Pharmaceutical Economics and Policy (9 papers), Innovation Policy and R&D (2 papers), Global Cancer Incidence and Screening (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Health Literacy and Information Accessibility (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Economics and Econometrics (63 citations), Oncology (39 citations), Immunology (28 citations), Virology (6 citations) and Pulmonary and Respiratory Medicine (33 citations). Alexander Roediger has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Lydia Makaroff, Nils Wilking, Kristine Sørensen, Gisela Kobelt, Christoph Zielinski, Thomas D. Szucs, Andrea Laslop, Anna Bucsics, Paul Robinson and Geoffrey Henning. Their work appears in journals such as Generics and Biosimilars Initiative Journal, Health Policy, Frontiers in Public Health, Journal of Cancer Policy and European Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.